EFFECT OF ZOLEDRONIC ACID AND PAMIDRONATE ON SKELETAL-RELATED EVENTS AND MORTALITY IN WOMEN WITH BONE METASTASES FROM BREAST CANCER IN A MANAGED CARE PLAN: A RETROSPECTIVE DATABASE ANALYSIS

被引：0
|
作者：
Henk, H. J. [2 ]
Kaura, S. [1 ]
机构：
[1] Novartis Pharmaceut, Florham Pk, NJ USA
[2] i3 Innovus, Eden Prairie, MN USA
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)71910-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A253 / A253
页数：1
相关论文
共 50 条
  • [21] Breast cancer patients without pain are at risk for skeletal-related events (SRES) and may have better outcomes with zoledronic acid compared with pamidronate
    Costa, Luis
    Chen, Yin-Miao
    Shirina, Nana
    ANNALS OF ONCOLOGY, 2006, 17 : 79 - 79
  • [22] Breast cancer patients without pain are at risk for skeletal-related events and may have better outcomes with zoledronic acid compared with pamidronate.
    Costa, L.
    Chen, Y. M.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S62 - S62
  • [23] The skeletal-related events of denosumab versus zoledronic acid in patients with bone metastases: A meta-analysis of randomized controlled trials
    Zhang, Zhicai
    Pu, Feifei
    Shao, Zengwu
    JOURNAL OF BONE ONCOLOGY, 2017, 9 : 21 - 24
  • [24] Influence of alcohol sensitivity on bone metastases and skeletal-related events in primary operable breast cancer: A retrospective cohort study
    Tanda, Naoko
    Tada, Hiroshi
    Washio, Jumpei
    Takahashi, Nobuhiro
    Ishida, Takanori
    Koseki, Takeyoshi
    PLOS ONE, 2022, 17 (06):
  • [25] ZOLEDRONIC ACID IS COST EFFECTIVE FOR THE PREVENTION OF SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES FROM RENAL CELL CARCINOMA: A FRENCH EXPLORATORY ANALYSIS
    Botteman, Marc F.
    Stephens, Jennifer M.
    Foley, Isaac
    Kaura, Satyin
    JOURNAL OF UROLOGY, 2009, 181 (04): : 500 - 500
  • [26] Skeletal-Related Events in Patients with Breast Cancer and Bone Metastases: Frequency, Predictors and Mortality in a Real-World Setting
    Diel, Ingo
    Hickstein, Lennart
    Jacob, Josephine
    Dornstauder, Eugen
    Kellner, Michael
    Hohmann, David
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 12 - 12
  • [27] Analysis of the cost-effectivenss of zoledronic acid for the prevention of skeletal-related events prostate cancer and bone metastases: A comparison across four European countries
    Botteman, M.
    Logman, F.
    Kaura, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [28] The impact of skeletal-related events on pain interference in patients with advanced breast cancer and bone metastases
    Fallowfield, Lesley
    Patrick, Donald L.
    Von Moos, Roger
    Cleeland, Charles S.
    Zhou, Ying
    Balakumaran, Arun
    Qian, Yi
    CANCER RESEARCH, 2015, 75
  • [29] Skeletal-related events (SREs) in breast cancer patients with bone metastases treated in the nontrial setting
    Trinkaus, Mateya
    Simmons, Christine
    Myers, Jeff
    Dranatisaris, George
    Clemons, Mark
    SUPPORTIVE CARE IN CANCER, 2010, 18 (02) : 197 - 203
  • [30] Skeletal-related events (SREs) in breast cancer patients with bone metastases treated in the nontrial setting
    Mateya Trinkaus
    Christine Simmons
    Jeff Myers
    George Dranatisaris
    Mark Clemons
    Supportive Care in Cancer, 2010, 18 : 197 - 203
12345